Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.

Shahbaz S, Bozorgmehr N, Koleva P, Namdar A, Jovel J, Fava RA, Elahi S.

PLoS Biol. 2018 Dec 14;16(12):e2006649. doi: 10.1371/journal.pbio.2006649. eCollection 2018 Dec.

2.

VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.

Ceeraz S, Eszterhas SK, Sergent PA, Armstrong DA, Ashare A, Broughton T, Wang L, Pechenick D, Burns CM, Noelle RJ, Vincenti MP, Fava RA.

Arthritis Res Ther. 2017 Dec 8;19(1):270. doi: 10.1186/s13075-017-1474-y.

3.

Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations.

Vinceti M, Malagoli C, Fabbi S, Kheifets L, Violi F, Poli M, Caldara S, Sesti D, Violanti S, Zanichelli P, Notari B, Fava R, Arena A, Calzolari R, Filippini T, Iacuzio L, Arcolin E, Mandrioli J, Fini N, Odone A, Signorelli C, Patti F, Zappia M, Pietrini V, Oleari P, Teggi S, Ghermandi G, Dimartino A, Ledda C, Mauceri C, Sciacca S, Fiore M, Ferrante M.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):583-589. doi: 10.1080/21678421.2017.1332078. Epub 2017 Jun 1.

PMID:
28569083
4.

Evaluation of early changes induced by diuron in the rat urinary bladder using different processing methods for scanning electron microscopy.

Fava RM, Ferragut Cardoso AP, da Rocha MS, Nascimento E Pontes MG, de Camargo JL, de Oliveira ML.

Toxicology. 2015 Jul 3;333:100-6. doi: 10.1016/j.tox.2015.04.006. Epub 2015 Apr 16.

5.

Can single use negative pressure wound therapy be an alternative method to manage keloid scarring? A preliminary report of a clinical and ultrasound/colour-power-doppler study.

Fraccalvieri M, Sarno A, Gasperini S, Zingarelli E, Fava R, Salomone M, Bruschi S.

Int Wound J. 2013 Jun;10(3):340-4. doi: 10.1111/j.1742-481X.2012.00988.x. Epub 2012 Jun 21.

PMID:
22716191
6.

AUF1/hnRNP D represses expression of VEGF in macrophages.

Fellows A, Griffin ME, Petrella BL, Zhong L, Parvin-Nejad FP, Fava R, Morganelli P, Robey RB, Nichols RC.

Mol Biol Cell. 2012 Apr;23(8):1414-22. doi: 10.1091/mbc.E11-06-0545. Epub 2012 Feb 29.

7.

Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.

Fava RA, Kennedy SM, Wood SG, Bolstad AI, Bienkowska J, Papandile A, Kelly JA, Mavragani CP, Gatumu M, Skarstein K, Browning JL.

Arthritis Res Ther. 2011;13(6):R182. doi: 10.1186/ar3507. Epub 2011 Nov 1.

8.

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.

Wang L, Rubinstein R, Lines JL, Wasiuk A, Ahonen C, Guo Y, Lu LF, Gondek D, Wang Y, Fava RA, Fiser A, Almo S, Noelle RJ.

J Exp Med. 2011 Mar 14;208(3):577-92. doi: 10.1084/jem.20100619. Epub 2011 Mar 7.

9.

LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR.

Fava RA, Browning JL, Gatumu M, Skarstein K, Bolstad AI.

Adv Exp Med Biol. 2011;691:383-90. doi: 10.1007/978-1-4419-6612-4_39. No abstract available.

PMID:
21153342
10.

Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10.

Kelly JA, Griffin ME, Fava RA, Wood SG, Bessette KA, Miller ER, Huber SA, Binder CJ, Witztum JL, Morganelli PM.

Cardiovasc Res. 2010 Jan 1;85(1):224-31. doi: 10.1093/cvr/cvp300.

11.

Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.

Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI.

Arthritis Res Ther. 2009;11(1):R24. doi: 10.1186/ar2617. Epub 2009 Feb 18.

12.

Speech perception ability in individuals with Friedreich ataxia.

Rance G, Fava R, Baldock H, Chong A, Barker E, Corben L, Delatycki MB.

Brain. 2008 Aug;131(Pt 8):2002-12. doi: 10.1093/brain/awn104. Epub 2008 May 30.

PMID:
18515321
13.

Distally based fasciocutaneous sural flap for foot reconstruction: a retrospective review of 10 years experience.

Fraccalvieri M, Bogetti P, Verna G, Carlucci S, Fava R, Bruschi S.

Foot Ankle Int. 2008 Feb;29(2):191-8. doi: 10.3113/FAI.2008.0191.

PMID:
18315975
14.

A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.

Bessette K, Lang ML, Fava RA, Grundy M, Heinen J, Horne L, Spolski R, Al-Shami A, Morse HC 3rd, Leonard WJ, Kelly JA.

Blood. 2008 Jan 1;111(1):344-50. Epub 2007 Sep 21.

15.

The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.

Fava RA, Elliott S, Raymond L, Mollmark J, Hays E, Honda T, Gribble GW, Sporn MB, Vincenti MP.

J Rheumatol. 2007 May;34(5):1058-68. Epub 2007 Mar 15.

PMID:
17361985
16.

Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function.

Browning JL, Allaire N, Ngam-Ek A, Notidis E, Hunt J, Perrin S, Fava RA.

Immunity. 2005 Nov;23(5):539-50.

17.

Quantitative ultrasound measurements of the calcaneus in the prediction of lumbar spine degeneration.

Mariconda M, Lotti G, Fava R, Midolo R, Longo C, Milano C.

Eur Spine J. 2004 Jul;13(4):346-53. Epub 2004 Feb 10.

18.

A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.

Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A, De Fougerolles AR, Sprague A, Browning JL.

J Immunol. 2003 Jul 1;171(1):115-26.

19.

Does vascular endothelial growth factor play a role in interleukin-6 receptor antagonist therapy for rheumatoid arthritis?

Gentiletti J, Fava RA.

Arthritis Rheum. 2003 Jun;48(6):1471-4. Review. No abstract available.

20.

Analysis of the function, expression, and subcellular distribution of human tristetraprolin.

Brooks SA, Connolly JE, Diegel RJ, Fava RA, Rigby WF.

Arthritis Rheum. 2002 May;46(5):1362-70.

21.

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P.

Nat Med. 2002 Aug;8(8):831-40. Epub 2002 Jul 1.

PMID:
12091877
22.
23.

The distally based superficial sural flap: our experience in reconstructing the lower leg and foot.

Fraccalvieri M, Verna G, Dolcet M, Fava R, Rivarossa A, Robotti E, Bruschi S.

Ann Plast Surg. 2000 Aug;45(2):132-9.

PMID:
10949339
24.

Factors influencing the outcome of degenerative lumbar spinal stenosis.

Mariconda M, Zanforlino G, Celestino GA, Brancaleone S, Fava R, Milano C.

J Spinal Disord. 2000 Apr;13(2):131-7.

PMID:
10780688
25.
26.

Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.

Paleolog EM, Fava RA.

Springer Semin Immunopathol. 1998;20(1-2):73-94. No abstract available.

PMID:
9836370
27.

[Our experience with a new material for skin graft areas].

Navissano M, Cerutti V, Malan F, Fava R, Tagliabue P.

Minerva Chir. 1995 Jan-Feb;50(1-2):115-9. Italian.

PMID:
7617247
28.

Collagen-induced arthritis as a model of rheumatoid arthritis.

Durie FH, Fava RA, Noelle RJ.

Clin Immunol Immunopathol. 1994 Oct;73(1):11-8. Review.

PMID:
7923907
29.

Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF.

J Exp Med. 1994 Jul 1;180(1):341-6.

30.
32.

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.

Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ.

Science. 1993 Sep 3;261(5126):1328-30.

PMID:
7689748
33.

Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration.

Calzetti S, Sasso E, Negrotti A, Baratti M, Fava R.

Clin Neuropharmacol. 1992 Dec;15(6):470-6.

PMID:
1477848
34.
35.

Determination of cimetidine and related impurities in pharmaceutical formulations by high-performance liquid chromatography.

Betto P, Ciranni-Signoretti E, Di Fava R.

J Chromatogr. 1991 Nov 8;586(1):149-52.

PMID:
1806550
36.

Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia.

Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, Davidson JM, Nanney LB, Lucas C, Townes AS.

J Exp Med. 1991 May 1;173(5):1121-32.

37.

Quantitative comparison of barbiturates in essential hand and head tremor.

Sasso E, Perucca E, Fava R, Calzetti S.

Mov Disord. 1991;6(1):65-8.

PMID:
2005924
38.

Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules.

Fava RA, Casey TT, Wilcox J, Pelton RW, Moses HL, Nanney LB.

Blood. 1990 Nov 15;76(10):1946-55.

PMID:
2242422
39.

Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor.

Calzetti S, Sasso E, Baratti M, Fava R.

Acta Neurol Scand. 1990 May;81(5):392-6.

PMID:
2375239
40.

Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis.

Sasso E, Perucca E, Fava R, Calzetti S.

Clin Neuropharmacol. 1990 Feb;13(1):67-76.

PMID:
2306749
41.

Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs.

Fava RA, McKanna J, Cohen S.

J Cell Physiol. 1989 Nov;141(2):284-93.

PMID:
2530241
42.
43.

Active and latent forms of transforming growth factor beta activity in synovial effusions.

Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T.

J Exp Med. 1989 Jan 1;169(1):291-6.

44.

The role of epidermal growth factor in skin diseases.

King LE Jr, Ellis DL, Gates RE, Inman WH, Stoscheck CM, Fava RA, Nanney LB.

Am J Med Sci. 1988 Sep;296(3):154-8. Review. No abstract available.

PMID:
3052058
45.

[Immunofluorescence of apparently healthy skin in rheumatoid arthritis].

Santiago MS, Fava R, Rodrigues CJ, Yoshinari NH, Cossermelli W.

Rev Hosp Clin Fac Med Sao Paulo. 1988 May-Jun;43(3):161-4. Portuguese. No abstract available.

PMID:
3074448
46.
47.

Fibronectin-associated transforming growth factor.

Fava RA, McClure DB.

J Cell Physiol. 1987 May;131(2):184-9.

PMID:
3495542
48.
50.

[Bioavailability from foods of trace elements: iron, zinc, copper, selenium, chromium, lead, cadmium, mercury].

Bocca A, Di Fava RC, Gaudiano A.

Ann Ist Super Sanita. 1984;20(2-3):149-69. Review. Italian. No abstract available.

PMID:
6400186

Supplemental Content

Support Center